Surgery may be best for advanced melanoma

April 5, 2017

(HealthDay)—Surgery to remove melanoma—the deadliest form of skin cancer—can extend the lives of patients whose disease has spread to the abdomen area, new research suggests.

Patients who get and to remove their cancer live twice as long—18 months on average—as those who only get medication, researchers found.

"Now that there are better options systemically, the decision-making about treatment has become more complex. Having this data available could potentially impact discussions about treatment and benefit long-term," said study leader Dr. Gary Deutsch, a cancer surgeon at Northwell Health in Great Neck, N.Y.

"I think the combination of immunotherapy with surgical therapy ... could potentially lead to curing more patients," he said in a health system news release.

Immunotherapy prompts a patient's immune system to destroy cancer cells. The U.S. Food and Drug Administration has approved it to treat melanoma, providing an alternative to standard chemotherapy for cancers that spread to other parts of the body. The researchers behind the new study said surgery to remove melanoma that has spread within the belly is rare.

For the study, Deutsch and his team analyzed the medical records of more than 1,600 patients treated for melanoma that had spread to the abdominal area. Of those, nearly 400 had surgery to remove their cancer.

Melanoma had spread to the liver in 697 patients, to the gastrointestinal tract in 336 patients and to the adrenal glands in 138 patients. It spread to the spleen in 109 patients and to the pancreas in 38. Another 305 patients' spread to several organs.

For patients who had surgery to remove their , the average survival time was 18 months, nearly 2.5 times longer than those who didn't have surgery.

The study was published April 5 in the journal JAMA Surgery.

Deutsch said he believes integrating surgery with newer drug treatments will greatly benefit patients.

Deutsch did the research as a surgical oncology fellow at the John Wayne Cancer Institute at Providence Saint John's Health Center in Santa Monica, Calif.

Explore further: Surgery on that has spread into abdomen more than doubles patient survival time

More information: The American Cancer Society provides more information on melanoma.

Related Stories

Surgery on that has spread into abdomen more than doubles patient survival time

October 8, 2015
Patients with metastatic melanoma who undergo surgery to remove lesions that have spread into the abdomen live more than twice as long as those treated with drug therapy alone, according to novel new research by a North Shore-LIJ ...

Liver tumor growth in mice slowed with new chemo-immunotherapy treatment

February 28, 2017
Hepatocellular carcinoma is the most common form of liver cancer, but treatment options are limited and many patients are diagnosed in late stages when the disease can't be treated. Now, University of Missouri School of Medicine ...

When breast cancer spreads to lungs, surgery may increase survival

April 1, 2013
(HealthDay)—Patients with breast cancer that has spread to the lungs may live longer if they have surgery to remove the lung tumors, a new study from Germany suggests.

Melanoma surgery delays are common for Medicare patients

April 8, 2015
One in five Medicare patients with melanoma experience delays in getting surgery, a Yale study found. The research was published April 8 in JAMA Dermatology.

Researchers find immunotherapy treatments better for advanced skin cancer

November 4, 2016
McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival ...

Research providing promising new treatments for melanoma

December 6, 2016
In a paper published online November 30, 2016, in Melanoma Management, Adam Riker, MD, Professor of Surgery and Chief of Surgical Oncology at LSU Health New Orleans School of Medicine, reviews approaches to manage melanoma, ...

Recommended for you

Study suggests colon cancer cells carry bacteria with them when they metastasize

November 24, 2017
(Medical Xpress)—A team of researchers working at Harvard University has found evidence that suggests a certain type of bacteria found in colon cancer tumors makes its way to tumors in other body parts by traveling with ...

Promising new treatment for rare pregnancy cancer leads to remission in patients

November 24, 2017
An immunotherapy drug can be used to cure women of a rare type of cancer arising from pregnancy when existing treatments have failed.

Researchers unravel novel mechanism by which tumors grow resistant to radiotherapy

November 23, 2017
A Ludwig Cancer Research study has uncovered a key mechanism by which tumors develop resistance to radiation therapy and shown how such resistance might be overcome with drugs that are currently under development. The discovery ...

African Americans face highest risk for multiple myeloma yet underrepresented in research

November 23, 2017
Though African-American men are three times more likely to be diagnosed with multiple myeloma, a type of blood cancer, most scientific research on the disease has been based on people of European descent, according to a study ...

Encouraging oxygen's assault on iron may offer new way to kill lung cancer cells

November 22, 2017
Blocking the action of a key protein frees oxygen to damage iron-dependent proteins in lung and breast cancer cells, slowing their growth and making them easier to kill. This is the implication of a study led by researchers ...

One in four U.S. seniors with cancer has had it before

November 22, 2017
(HealthDay)—For a quarter of American seniors, a cancer diagnosis signals the return of an old foe, new research shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.